| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.072 | 0.2 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.23 | 0.2 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |